Phase 3 Clinical Trial Results on J&J’s COVID-19 Vaccine to Be Released Soon
Johnson & Johnson (J&J) may publish data from its COVID-19 vaccine’s Phase 3 clinical trial as early as the end of January. The 45,000 subject study began on December 17, 2020. If the results demonstrate the vaccine’s safety and…